Image from Google Jackets

Formulation of liquid dosage form with the isolated citric acid from suha (citrus maxima) : basis for stability studies / Eunice Banting, Sofia Julia Cortez, Chrislyn Ann Joy Gloton, Richbern Sayson, and Adelyne Tud.

By: Contributor(s): Material type: TextTextEAC Cavite : School of Pharmacy, 2025Description: vii, 95 pages ; 28 cmContent type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
LOC classification:
  • T PHAR F67 2025
Summary: Citrus maxima is known to contain different bioactive chemical constituents, among which is citric acid, used in the pharmaceutical industry and recognized for its antioxidant qualities. The citric acid present in the Citrus maxima has limited research in regard to the incorporation of the citric acid in a liquid dosage form. The purpose of the study is to formulate a physically stable liquid dosage form with the use of citric acid isolated from the fruit Citrus maxima. The juice from the pulp of the fruit, from which the citric acid was isolated, reveals a 19.76% yield of citric acid. The suha juice was diluted (distilled water) and neutralized (NaOH) with a 7.00 to 7.20 pH level. The sample underwent various heating processes to crystallize. FTIR analysis indicated the presence of citric acid, and impurity tests showed moisture content (32.71% to 37.70%). Concentration from titration of citric acid (0.031 to 0.040 M). The stability of the liquid dosage form incorporated with the isolated citric acid revealed an acidic pH, stable temperature, and physical properties. The thin chromatography analysis using solvent (distilled water, acetic acid, and butanol) for the detection of citric acid and identification of RF value (0.95 to 0.98), revealing the presence of citric acid. The pH (4.05-4.18) of the formulation at various temperatures for one month shows its stability over an extended period. In conclusion, the citric acid isolated from the Citrus maxima fruit helps stabilize the formulated liquid dosage.
List(s) this item appears in: Thesis - Bachelor of Science in Pharmacy
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Barcode
THESIS EAC Library Cavite EAC Cavite-Thesis Section T PHAR F67 2025 (Browse shelf(Opens below)) Available ML-TH2851

Experimental research

Includes bibliographical references

Citrus maxima is known to contain different bioactive chemical constituents, among which is citric acid, used in the pharmaceutical industry and recognized for its antioxidant qualities. The citric acid present in the Citrus maxima has limited research in regard to the incorporation of the citric acid in a liquid dosage form. The purpose of the study is to formulate a physically stable liquid dosage form with the use of citric acid isolated from the fruit Citrus maxima. The juice from the pulp of the fruit, from which the citric acid was isolated, reveals a 19.76% yield of citric acid. The suha juice was diluted (distilled water) and neutralized (NaOH) with a 7.00 to 7.20 pH level. The sample underwent various heating processes to crystallize. FTIR analysis indicated the presence of citric acid, and impurity tests showed moisture content (32.71% to 37.70%). Concentration from titration of citric acid (0.031 to 0.040 M). The stability of the liquid dosage form incorporated with the isolated citric acid revealed an acidic pH, stable temperature, and physical properties. The thin chromatography analysis using solvent (distilled water, acetic acid, and butanol) for the detection of citric acid and identification of RF value (0.95 to 0.98), revealing the presence of citric acid. The pH (4.05-4.18) of the formulation at various temperatures for one month shows its stability over an extended period. In conclusion, the citric acid isolated from the Citrus maxima fruit helps stabilize the formulated liquid dosage.

There are no comments on this title.

to post a comment.